A Multicenter, Non-interventional Study With Neupro to Evaluate the Perception of Pain Associated With Idiopathic Parkinson's Disease
Latest Information Update: 06 Apr 2018
Price :
$35 *
At a glance
- Drugs Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Pharmacodynamics
- Acronyms NEUPAD
- Sponsors UCB
- 07 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Jul 2014 Planned End Date changed from 1 Jun 2014 to 1 Jul 2014 as reported by ClinicalTrials.gov.
- 01 Jul 2014 Planned primary completion date changed from 1 Jun 2014 to 1 Jul 2014 as reported by ClinicalTrials.gov.